What Dow Development Laboratories does

Dow Development Laboratories (DDL) is a specialty contract development and manufacturing organization (CDMO) focused on topical pharmaceutical drug products. Founded in 2013 and headquartered in a 23,000-square-foot custom-built facility in Petaluma, California, the company provides formulation design, analytical method development and validation, GMP manufacturing of clinical supplies, clinical packaging and labeling, and CMC documentation support. DDL specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, and suspensions, and has expanded into ophthalmic product development. The company is FDA-registered and operates under cGMP and GLP quality standards, with batch capabilities spanning 1 kg laboratory scale up to over 1,000 kg commercial scale.

Technically, DDL leverages deep expertise in formulation chemistry including solubility enhancement, excipient compatibility, preservation systems, lipid-based systems, nanotechnology, microneedles, encapsulation technologies, and proprietary silicone-based microemulsion systems. The firm also conducts research on critical material attributes of compendial raw materials and their impact on drug product viscosity, degradation, and appearance. A flagship commercial outcome was DDL's end-to-end support of Arcutis Biotherapeutics' Zoryve (roflumilast) cream 0.3% from inception through FDA approval in 2022.

DDL generates revenue on a fee-for-service, project-based model, selling directly to pharmaceutical and biotech company sponsors through sales-led business development with dedicated project managers and technical team leaders. Its go-to-market is reinforced by thought-leadership content (FormulationForum blog, resources library, Dow Development Institute) and scientific poster presentations at conferences such as AAPS PharmSci360. DDL operates as a subsidiary of Symbio, a diversified R&D group, and serves clients globally from its single Northern California facility.

Name

Dow Development Laboratories

Legal name

Dow Development Laboratories, LLC

Website

https://dowdevelopmentlabs.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Dow Development Laboratories is a specialty CDMO providing formulation development, analytical testing, GMP manufacturing, and clinical packaging for topical and ophthalmic pharmaceutical drug products, serving pharmaceutical and biotech sponsors from its FDA-registered, cGMP-compliant facility in Petaluma, California.

Ownership category

akta.pro rank

Headquarters

HQ city

Petaluma

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Pharmaceutical Development Services: DDL generates revenue through providing fee-for-service contract development and manufacturing services to pharmaceutical and biotech companies. Services include formulation development, analytical method development, GMP manufacturing, clinical packaging and labeling, and regulatory support. Revenue is project-based with contracts typically spanning development programs from inception through regulatory approval.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Dow Development Laboratories is a specialty contract development and manufacturing organization (CDMO) that provides topical pharmaceutical drug product formulation, development, manufacturing, testing, packaging, and labeling services to pharmaceutical and biotech companies. The company specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, suspensions, and pastes, supporting clients from formulation inception through FDA approval. Operations are conducted at an FDA-registered, cGMP-compliant 23,000 square foot facility in Petaluma, California.

Product overview

Dow Development Laboratories (DDL) is a specialty contract development and manufacturing organization (CDMO) providing comprehensive services for topical pharmaceutical drug product development. The company operates as a single unified offering combining formulation design, analytical methods development, manufacturing, and clinical packaging services. The core portfolio includes Topical Formulation Design and Development, Topical Drug Product Testing with Methods & Stability Studies, Ophthalmic Product Development, Drug Product Manufacturing, and Clinical Packaging & Labeling. These services are complemented by CMC Documentation Support and the Dow Development Institute educational arm. The company specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, and pastes for various therapeutic indications.

Differentiator

Problem solved

Functional benefit

Products and services

• Topical Formulation Design and Development Contract formulation development services for semi-solid and liquid topical drug products including gels, creams, ointments, solutions, sprays, and suspensions for dermatologic, ophthalmic, women's and men's health, pain, wound healing, and infection indications. Includes solubility studies, excipient compatibility studies, prototype formulation design, and lead formulation selection for IND-enabling studies under GLP.
• Topical Drug Product Testing, Methods & Stability Studies Comprehensive analytical and quality testing services for topical pharmaceutical products including analytical method development and validation (HPLC assay methods for preserved formulations), ICH stability studies, packaging compatibility testing, and quality control testing.
• Ophthalmic Product Development Specialized contract development services for ophthalmic drug products requiring fundamentally different analytical and formulation approaches from semi-solid dosage form development.
• Drug Product Manufacturing (Clinical Supplies) R&D, GLP, and GMP contract manufacturing and filling of topical drug products including gels, creams, ointments, solutions, sprays, and pastes for clinical trial supplies, with batch capacity up to 40 kilograms and scale-up capabilities from 1 kg to over 1,000 kg.
• Clinical Packaging & Labeling GMP clinical supplies packaging, labeling, and distribution services for pharmaceutical products entering clinical trials.
• CMC Documentation Support & Product Development Consulting Consulting services for clients new to topical drug development, including regulatory guidance, CMC documentation support, and decision-making support across the development program.

Quantifiable outcome

• Successful FDA approval of Zoryve (roflumilast) cream 0.3% for plaque psoriasis in 2022

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Symbioparent companyOthersSymbio is the parent company of Dow Development Laboratories (DDL). DDL operates as a subsidiary of Symbio, leveraging the parent company's resources and infrastructure while maintaining specialized focus on topical pharmaceutical development.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Tapemark: Tapemark is a specialty CDMO focused on topical and transdermal drug product development and manufacturing, including formulation, scale-up, and clinical/commercial supply. Highly comparable to DDL given the shared topical semi-solid and liquid dosage form specialization and similar SMB CDMO positioning.
• Tergus Pharma: Tergus Pharma is a niche CDMO specializing in semi-solid and liquid topical pharmaceutical development, including formulation, analytical, and GMP manufacturing services. Directly comparable to DDL's core service portfolio in gels, creams, and ointments for dermatology and adjacent indications.
• Halo Pharma: Halo Pharma is a CDMO offering formulation, development, and manufacturing for semi-solid and liquid topical dosage forms, including clinical and commercial supply. Comparable to DDL through shared topical CDMO positioning and pharmaceutical client base.

Broad incumbents

• Hovione: Hovione is a CDMO specializing in oral, inhaled, and topical drug product development and manufacturing, with semi-solid and cream formulation capabilities. Comparable to DDL via shared topical formulation services, though Hovione operates globally with substantially broader capacity.
• PCI Pharma Services: PCI Pharma Services is a global CDMO offering formulation development, clinical and commercial manufacturing, and packaging services across sterile and non-sterile dosage forms including topicals. Comparable to DDL's CDMO service model, though PCI operates at significantly larger scale and modality breadth.
• Thermo Fisher Scientific (Patheon): Thermo Fisher's Patheon business is a global CDMO providing formulation, analytical, and commercial manufacturing across multiple dosage forms including topical semi-solids. Comparable to DDL as a CDMO serving pharma and biotech, though operates at much greater scale and modality breadth.
• Catalent (Novo Holdings): Catalent (now owned by Novo Holdings) is a global full-service CDMO offering topical, oral, and injectable drug product development and manufacturing at commercial scale. Comparable to DDL via its topical and semi-solid dose capabilities, but much larger and broader in modality.

Regional players

• Pillar5 Pharma: Pillar5 Pharma is a Canadian CDMO offering semi-solid and liquid topical pharmaceutical manufacturing, including creams, ointments, and gels for clinical and commercial supply. Comparable to DDL's topical CDMO focus and SMB scale, but operates primarily in North America from a single non-US facility.
• Groupe Parima: Groupe Parima is a Canadian CDMO specializing in semi-solid and liquid topical pharmaceutical development and manufacturing, including formulation, GMP manufacturing, and packaging. Comparable to DDL through topical CDMO services and SMB scale, with primary Canadian/regional presence.

Emerging players

• Velesco Pharma: Velesco Pharma is a small CDMO providing early-phase formulation development and cGMP manufacturing for liquids, creams, and ointments. Comparable to DDL in early-development topical services and as a nimble specialty CDMO targeting biotech clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dow Development Laboratories